FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

395805008: Moxonidine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469745016 Moxonidine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489446010 Moxonidine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4501431000005113 Moxonidin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxonidine (substance) Is a Imidazoline receptor agonist true Inferred relationship Some
Moxonidine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Imidazoline receptor agonist (disposition) true Inferred relationship Some
Moxonidine (substance) Is a Pyrimidine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing moxonidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 200 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some
Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some
Moxonidine 300micrograms tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some
Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some
Product containing precisely moxonidine 200 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 200 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 200 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxonidine (substance) Inferred relationship Some 1
Product containing precisely moxonidine 300 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxonidine (substance) Inferred relationship Some 1
Moxonidine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxonidine (substance) Inferred relationship Some 1
Product containing only moxonidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxonidine (substance) Inferred relationship Some 1
Product containing only moxonidine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Moxonidine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start